Perioada | Titlu | Speaker |
---|---|---|
10.00 - 11.30 | Systemic lupus erythematosus: 2020 update - Sesiune stiintifica cu sprijinul GSK - |
|
10:00 - 10:30 | The complex clinical picture of systemic lupus erythematosus and the development of the 2019 EULAR/ACR classification criteria | Marta Mosca (Pisa) |
10:30 - 11:00 | The management of SLE: Evolving concepts and implications for clinical practice | Dimitrios Boumpas (Atena) |
11:00 - 11:30 | Overlap connective tissue disease syndromes | Simona Rednic |
11:50 - 13:40 | Spondiloartritele în actualitate | |
11:50 - 12:20 | Latest insights in spondyloarthritis - Prezentare stiintifica cu sprijinul Abbvie - |
Robert Landewe (Amsterdam) |
12:20 - 12:35 | Perspectiva reumatologului asupra uveitei din spondiloartrite | Denisa Predeteanu |
12:35 - 13:05 | Psoriatic spondyloarthritis or ankylosing spondylitis with psoriasis? Similarities and differences in daily routine practice - Prezentare stiintifica cu sprijinul Novartis - |
Xenofon Baraliakos (Herne) |
13:05 - 13:20 | Consensul OMERACT pentru definirea si scorarea ecografica a entezitelor | Florian Berghea |
13:20 - 13:40 | Bolile inflamatoare intestinale si spondiloartrita - Prezentare stiintifica cu sprijinul Pfizer - |
Ruxandra Ionescu |
14:00 - 15:40 | Artropatia psoriazică în actualitate | |
14:00 - 14:20 | Patogenia afectarii osoase in artrita psoriazica - Prezentare stiintifica cu sprijinul Novartis - |
Andra Bălănescu |
14:20 - 14:50 | Targets and Outcomes in PSA - Prezentare stiintifica cu sprijinul Pfizer - |
Daniel Aletaha (Viena) |
14:20 - 15:10 | Comorbiditatile in artrita psoriazica - Prezentare stiintifica cu sprijinul Lilly - |
Magda Pârvu |
15:10 - 15:25 | Manifestari extraarticulare in artropatia psoriazica - Prezentare stiintifica cu sprijinul Novartis - |
Violeta Bojinca |
15:25 - 15:40 | Imagistica in artrita psoriazica sau “Cu ochii larg...deschisi" - Prezentare stiintifica cu sprijinul Novartis - |
Florin Vreju |
Perioada | Titlu | Speaker |
---|---|---|
08:00 - 09:30 | Session VI - Original research in IBD | |
Understanding the Impact of Ulcerative Colitis and its Associated Disease Burden on Patients (ICONIC Study) – Data of Study from Romanian Patients | D. Dobru, C. Cijevschi, E.Dumitru |
|
The COVID19 pandemic impact on Inflammatory Bowel Disease Patients Management in a Tertiary Gastroenterology Center | Roxana Costache, A. Saizu, R. Iacob |
|
Correlations between sleep quality and clinico-biological parameters in patients with inflammatory bowel disease | Georgiana-Emmanuela Gîlcă-Blanariu, Gabriela Ștefănescu, Cristinel Ștefănescu, Anca Victorița Trifan |
|
The prevalence of ulcerative colitis and Crohn’s disease in North-Eastern Romania - the impact of the COVID-19 pandemic | Laura Huiban, Carol Stanciu, Cristina Maria Muzîca |
|
Clinical impact of small bowel capsule endoscopy in obscure gastrointestinal bleeding | Ana-Maria Singeap, Camelia Cojocariu, Irina Girleanu |
|
The Health-related Quality of Life of Patients with Inflammatory Bowel Disease in remission in a Romanian Tertiary Care Center | Stroie Tudor, Diculescu Rucsandra, Stănciulea Oana |
|
Clinical remission in ulcerative colitis, treatment and risk in pregnancy? Case study and review | Carmen Anton, E.Anton, Smaranda Diaconescu |
|
09:30 - 10:00 | Complex Perianal Fistula approach in the light of new therapies | |
Innovative stem cell therapy and who are the suitable patient for it? | Cristian Gheorghe | |
Challenges of stem cell administration | Oana Stanciulea, Iulian Mosteanu |
|
- Educational session organized by RCCC with the support of Takeda - | ||
10:00 - 11:15 | Session VII - Malignancy in IBD patients – how to deal with? | |
Introduction: Malignancies in inflammatory bowel diseases | Anca Trifan | |
Colorectal cancer prevention in long standing inflammatory bowel diseases | Roxana Zaharie | |
Endoscopic surveillance in long standing inflammatory bowel diseases | Simona Bataga | |
Difficulties in endoscopic surveillance in inflammatory bowel diseases | Catalin Sfarti, Stefan Chiriac, Gabriela Stefanescu |
|
Colorectal Cancer in inflammatory bowel diseases – A retrospective cohort study | Andreea Chifulescu Teodora Manuc, Carmen Preda |
|
Extracolonic malignancies in patients with inflammatory bowel diseases – A retrospective cohort study | Camelia Cojocariu, Ana Maria Singeap, Oana Petrea |
|
Choice of biologics in IBD patients with treated malignancies: case report and literature review | Cristian Tieranu, Tudor Arbanas, Mirela Ionescu |
|
11:15 - 11:30 | Pauza | |
11:30 - 11:45 | The implications of the microbiome in gastrointestinal pathology | |
The role of microbiota in the management of Irritable Bowel Syndrome (Probicol, Bifido Plus) | Mircea Diculescu | |
The role of microbiota in the management of Inflammatory Bowel Diseases (Sinergin) | Liana Gheorghe | |
- Educational session organized by RCCC with the support of Innergy - | ||
11:45 - 12:00 | Educational session organized by RCCC with the support of Fresenius Kabi | Dan Gheonea |
12:00 - 13:00 | Session VIII - Current therapeutic strategies in 2020 | |
Treat to target strategy in IBD in 2020 | Roxana Zaharie | |
Surgery in IBD – current approach in 2020 | Traian Dumitrascu | |
Stopping biologicals/immunomodulators in IBD? | Razvan Iacob | |
Discussions | ||
13:00 - 13:30 | Review of best articles | Liana Gheorghe, Roxana Vădan |
13:30 - 14:00 | Conclusions | |
14:00 - 14:30 | RCCC General Assembly |
Perioada | Titlu | Speaker |
---|
Perioada | Titlu | Speaker |
---|